Induced pluripotent stem cells (iPSCs) hold great promise for personalized regenerative medicine. However, recent studies show that iPSC lines carry genetic abnormalities, suggesting that reprogramming may be mutagenic. Here, we show that the ectopic expression of reprogramming factors increases the level of phosphorylated histone H2AX, one of the earliest cellular responses to DNA double-strand breaks (DSBs). Additional mechanistic studies uncover a direct role of the homologous recombination (HR) pathway, a pathway essential for error-free repair of DNA DSBs, in reprogramming. This role is independent of the use of integrative or nonintegrative methods in introducing reprogramming factors, despite the latter being considered a safer approach that circumvents genetic modifications. Finally, deletion of the tumor suppressor p53 rescues the reprogramming phenotype in HR-deficient cells primarily through the restoration of reprogramming-dependent defects in cell proliferation and apoptosis. These mechanistic insights have important implications for the design of safer approaches to creating iPSCs.
INTRODUCTION
Pioneering work by Yamanaka and colleagues has identified key transcription factors that enable the reprogramming of somatic cells to a pluripotent state (Takahashi and Yamanaka, 2006) . This technology has been used to generate human induced pluripotent stem cells (iPSCs), which closely resemble embryonic stem cells (ESCs) in terms of differentiation potential, selfrenewal capacity, transcriptional profile, and epigenetic state (Hochedlinger and Plath, 2009; Okita and Yamanaka, 2011) . Like ESCs, iPSCs can be differentiated into a wide range of cell types, allowing the generation of patient-specific cells suitable for cell-replacement therapy and disease modeling.
Despite this great promise, a number of studies suggest that reprogramming and the subsequent expansion of iPSCs in culture lead to the accumulation of diverse genetic abnormalities at chromosomal, subchromosomal, and nucleotide levels (Gore et al., 2011; Hussein et al., 2011; Laurent et al., 2011; Mayshar et al., 2010) . The source of these genetic lesions remains under debate. Some reports attribute them primarily to clonal capture of variant cells within the donor cell population (Cheng et al., 2012; Young et al., 2012 ), yet another study suggests that approximately half of the mutations arise de novo during reprogramming (Gore et al., 2011) . This has prompted us to examine the roles of the homologous recombination (HR) DNA repair pathway in reprogramming and whether reprogramming is a trigger of DNA damage.
We used a drug-inducible system to discriminate the effects of reprogramming from viral integration, because the latter is known to cause DNA double-strand breaks (DSBs). The results show that the ectopic expression of reprogramming factors is sufficient to induce DNA DSBs, providing a plausible molecular mechanism for genetic abnormalities observed in iPSC lines. Furthermore, efficient reprogramming requires key HR genes, including Brca1, Brca2, and Rad51, independently of the methods used to introduce reprogramming factors. Finally, deletion of the tumor suppressor p53 largely restores normal reprogramming in HR-deficient mouse embryonic fibroblasts (MEFs), accompanied by a correction of reprogramming-dependent defects in cell proliferation and apoptosis. These findings provide important mechanistic insights into reprogramming and have important implications for designing rational approaches for the generation of lesion-free iPSCs suitable for clinical applications.
RESULTS
Reprogramming Induces DSBs DNA DSBs can be triggered by a number of DNA-damaging agents, such as g-irradiation and oxidative stress. Excessive accumulation of DSBs in a cell leads to growth arrest, apoptosis, or mutations in the genome. Ectopic expression of the reprogramming factors Oct4, Sox2, Klf4, and c-Myc or Oct4, Sox2, and Klf4 (hereafter referred to as 4F or 3F, respectively) allows the reprogramming of MEFs to a pluripotent state (Hochedlinger and Plath, 2009; Okita and Yamanaka, 2011) . Transduction of 4F or 3F with constitutive retroviral expression vectors has been shown to increase the number of cells with phosphorylated histone H2AX (gH2AX) nuclear foci, one of the earliest cellular responses to DSBs (Kawamura et al., 2009; Mü ller et al., 2012) . However, it is unclear whether DSBs are caused by reprogramming or by viral transgene integration, given that the latter is known to cause DSBs (Skalka and Katz, 2005) . To determine whether there is a direct link between epigenetic reprogramming and increased DNA DSBs, we used doxycycline-inducible lentiviral vectors (FUWtetO) to express reprogramming factors in wild-type (WT) MEFs and assessed gH2AX through flow cytometry (Huang and Darzynkiewicz, 2006) . The effects of reprogramming genes were determined by comparing infected cells within the same pool with or without doxycycline treatment. We found that 4F-and 3F-infected MEFs showed a $6-fold and a 3-fold increase, respectively, of gH2AX + cells after 5 days of doxycycline treatment in comparison to infected-butuntreated or noninfected MEFs, whereas doxycycline treatment alone on noninfected MEFs had no effect ( Figures 1A and 1B ). This correlated with the acquisition of an early reprogramming marker (SSEA1) and a marked increase in the percentage of cells undergoing apoptosis, as identified by Annexin V staining ( Figures 1A, 1C, and 1D ). Expressing c-Myc alone also had an effect, consistent with a previous report (Karlsson et al., 2003) , whereas expressing other reprogramming factors individually or in combination (Oct4 and Sox2) had no significant effect ( Figure 1B ).
Because nonintegrative methods are thought to generate safer iPSCs for clinical use, we measured gH2AX + cells during reprogramming using a nonintegrative approach that was based on the use of ''reprogrammable'' MEFs (Carey et al., 2010; Stadtfeld et al., 2010) . We generated reprogrammable MEFs by combining an allele constitutively expressing the reverse tetracycline-controlled transactivator (rtTA) from the Rosa26 locus with a doxycycline-inducible polycistronic reprogramming cassette (OKSM) targeted to the Col1A1 locus (Stadtfeld et al., 2010) . This system allows homogeneous expression of the reprogramming factors ideal for studies of reprogramming. Using flow cytometry, we analyzed the percentage of gH2AX + cells at different time points after doxycycline treatment. Additionally, we used the pluripotency cell surface marker SSEA1 to identify early reprogramming cells in doxycycline-treated conditions (Brambrink et al., 2008) . We observed the same low levels of gH2AX expression in both untreated MEFs and SSEA1 À cells in the doxycycline-treated condition ( Figure 1E ). In contrast, there was a significant increase in the percentage of gH2AX + cells in the SSEA1 + population in doxycycline-treated cells. This increase occurred early and remained constant during the reprogramming process. These results demonstrate that reprogramming, rather than viral integration, is directly responsible for the accumulation of gH2AX in cells.
Reprogramming Is Impaired in Brca1 and Brca2
Mutant MEFs
In mammalian cells, three pathways have been described for the repair of DSBs: HR, nonhomologous end-joining (NHEJ), and single-strand annealing (SSA) (Moynahan and Jasin, 2010) . HR is responsible for the accurate repair of DNA damage using the sister chromatid as a template. In contrast, repairs by NHEJ and SSA are intrinsically error-prone and can lead to deletions and other types of mutations. Previous studies have shown that fibroblasts defective for the Fanconi anemia (FA) complementation group are resistant to reprogramming through classic viral-infection-based methods (Mü ller et al., 2012; Raya et al., 2009) . These studies suggest a potential link between HR and reprogramming, given that several FA pathway components have been shown to promote HR (Nakanishi et al., 2005) . However, a direct role of HR in reprogramming has not been established because FA proteins also have distinct functions independent of HR. We examined the role of Brca1 and Brca2, two genes essential for homology-directed DNA repair, during reprogramming using homozygous MEFs generated from three hypomorphic mutant alleles. Brca1
Tr carries an insertion within exon 11, leading to a truncated Brca1 protein with 924 amino acids (Ludwig et al., 2001 ). The second Brca1 allele, Brca1 S1598F , contains a point mutation in the Brca1 C-terminal domain which disrupts the interaction of Brca1 with the phosphorylated isoforms of several repair proteins including, Abraxas (CCDC98), BACH1 (FancJ), and CtIP (Shakya et al., 2011) . The Brca2 D27 allele harbors a deletion of exon 27, which generates a truncated protein lacking 187 C-terminal amino acids (McAllister et al., 2002) . All three mutations impair homology-directed DNA repair. Adult mice that are homozygous for each of these mutations are identified from crosses of heterozygous animals, suggesting that these mutations do not significantly affect cell growth or survival in vivo.
In WT MEFs, we typically detected $300 alkaline phosphatase (AP) + colonies and $100 Nanog + colonies 3 weeks after plating of 50,000 4F-infected cells using the constitutive retroviral expression vector pMXs (Figures 2A and 2B ). In contrast, the numbers of AP + and Nanog + colonies were significantly reduced (up to $20-fold) in Brca1 and Brca2 homozygous mutant MEFs when compared to WT control MEFs ( Figures 2B-2D ). By picking colonies with iPSC-like morphology, we were able to establish Brca2 mutant iPSC lines with comparable efficiency ($40%) to WT controls ( Figure S1A ). Brca2 mutant iPSCs were indistinguishable from control WT iPSCs in expression of Nanog and other pluripotency markers by real-time quantitative RT-PCR (qRT-PCR) and immunohistochemical analysis ( Figure S1B and S1D). The rates of proliferation and apoptosis were not significantly different between Brca2 mutant iPSC lines in comparison to control WT lines (Figures S1E-S1H). Therefore, the reprogramming phenotypes observed in Brca2 mutant MEFs are not due to impaired proliferation and/or increased apoptosis of HR-deficient iPSCs formed during reprogramming. However, we were not able to establish a bona fide iPSC line from Brca1 mutant MEFs out of the ten colonies picked ( Figure S1A ). The best Brca1 mutant lines appeared partially reprogrammed, exhibiting only occasional Nanog staining by immunohistochemical analysis. In comparison to Brca2 mutant and WT iPSC lines, Brca1 mutant lines exhibited limited upregulation of the pluripotency gene Nanog, accompanied by incomplete silencing of the fibroblast marker Col6a1 and reprogramming transgenes (Figures S1B-S1D ). These data show that both Brca1 and Brca2 are required for efficient reprogramming, and that Brca1 may also be required for iPSC-line establishment. Next, we examined whether mutations in Brca1 and Brca2 affect 3F reprogramming without c-Myc, the overexpression of which alone increases DNA DBSs. Using doxycycline-inducible lentiviral expression vectors (FUW-tetO) to express 3F, we detected $150 AP + colonies and $40 Nanog + colonies 3 weeks after plating 50,000 infected, doxycycline-treated WT MEFs. As in 4F reprogramming, both Brca1 and Brca2 homozygous mutant MEFs showed up to a 20-fold reduction in the number of AP + colonies ( Figures 2E and 2F ). Moreover, no Nanog + colonies were detected ( Figure 2G ) from mutant MEFs. These results support a critical role of Brca1 and Brca2 in both 3F and 4F reprogramming independent of the infection method used to introduce reprogramming factors.
Finally, to establish a direct link between reprogramming and HR-mediated DNA repair, we compared the percentage of gH2AX + cells in Brca1 Tr/Tr versus WT MEFs during reprogramming ( Figure 2H ). We detected a significant increase in the percentage of gH2AX + cells in both 4F-and 3F-expressing mutant cells in comparison to WT controls. These data, along with the established roles of Brca1 and Brca2 in HR, strongly suggest a direct involvement of HR-mediated DNA DSB repair in reprogramming.
HR Genes Play a Direct Role during Reprogramming
Brca1 and Brca2 mutant MEFs may have accumulated genetic or cellular alterations during their culture before reprogramming, Figures  3D, 3E , S3F, and S3G).
The Requirement of HR Genes Is Independent of Viral Integration The experiments described above introduced reprogramming genes with the use of classic viral-infection-based methods commonly used in reprogramming studies. However, viral integration triggers DNA DSBs (Skalka and Katz, 2005) , which may necessitate HR-mediated DNA repair. Therefore, we proceeded to determine the requirement of HR genes in the absence of viral infection using reprogrammable MEFs. We infected reprogrammable MEFs with shRNAs targeting HR genes and added doxycycline to initiate reprogramming. Using a control shRNA, we detected, on average, $600 alkaline AP + colonies ( Figures 3D   and 3F ) and $500 Nanog + colonies ( Figure 3G ) from 50,000 reprogrammable MEFs after $3 weeks of doxycycline treatment. shRNAs against Brca1, Brca2, and Rad51 all led to a marked decrease in the number of both AP + and Nanog + colonies ( Figures 3D, 3F , 3G, and S3H). These results demonstrate that DNA damage increases during reprogramming independently of viral integration and that the HR pathway is also required for efficient reprogramming through nonintegrative methods.
p53 Deletion Rescues Reprogramming Defects of HR-Deficient MEFs
Because cells with excessive DNA damage are typically eliminated through p53-dependent apoptosis or growth arrest, we hypothesized that deletion of p53 would rescue the reprogramming defects in HR-deficient MEFs. This would be consistent with an established role of the p53 pathway in limiting the rate of reprogramming (Spike and Wahl, 2011) . We performed 4F reprogramming on MEFs derived from Brca2 homozygous mutant and WT embryos and used a wellcharacterized shRNA to simultaneously suppress p53 (Hemann et al., 2003) . Downregulating p53 significantly increased reprogramming efficiency in both mutant and WT MEFs, though the reprogramming efficiency of mutant MEFs was not rescued to WT levels ( Figures 4A-4C ). This partial rescue may be due to incomplete inactivation of p53 with the knockdown approach ( Figure S4A ). To further investigate the role of p53 in HR-deficient MEFs, we generated p53 À/À mutant MEFs (Jacks et al., 1994) and performed 4F reprogramming experiments while using shRNAs against Brca1, Brca2, and Rad51. In WT control MEFs, knockdown of HR genes caused a significant reduction in the number of AP + and Nanog + colonies ( Figures 4D-4F Figures 4D-4F ).
To further investigate the cellular mechanisms, we analyzed cell proliferation and apoptosis during reprogramming by immunostaining for the mitotic marker phospho-Histone H3 and the apoptotic marker cleaved Caspase-3. During 4F reprogramming of WT control MEFs, HR deficiency caused a significant decrease in the percentage of proliferating cells and an increase of apoptotic cells ( Figures 4G, 4H, S4C, and S4D ). In contrast, during 4F reprogramming of p53 À/À MEFs, HR deficiency failed to cause any significant defects in cell proliferation or apoptosis (some increase was observed in apoptosis, though it was not statistically significant) ( Figures 4G, 4H , S4C, and S4D). These results suggest that a defective HR pathway leads to an increased number of cells accumulating DNA damage during reprogramming. p53-mediated growth arrest and apoptosis is responsible for the elimination of these cells and, consequently, a significant decrease in reprogramming efficiency. Although downregulating p53 rescues the reprogramming phenotype in HR-deficient MEFs, it may also allow the generation of iPSCs with genetic aberrations ( Figure 4I ).
DISCUSSION
Current reprogramming strategies rely on the ectopic expression of defined sets of pluripotency-associated transcription factors (Hochedlinger and Plath, 2009; Okita and Yamanaka, 2011) . The recent development of nonintegrative methods for introducing reprogramming genes theoretically circumvents undesirable genetic modifications in iPSCs caused by transgene insertions in classic reprogramming approaches (Gonzá lez et al., 2011) . However, surveys of iPSCs generated with both integrative and nonintegrative methods reveal significant genetic abnormalities (Gore et al., 2011; Hussein et al., 2011; Laurent et al., 2011; Mayshar et al., 2010) . Here, we show that ectopic expression of reprogramming factors increases the level of the DNA DSB marker gH2AX independently of viral integration. This effect may be linked to oncogenic activities of reprogramming factors (Daley, 2008) . On the other hand, epigenetic remodeling, including global DNA demethylation, may also contribute to DNA damage during reprogramming. Although the mechanisms by which 5-methylcytosine is converted into cytosine in CpG islands are not yet well understood, prevailing models suggest that this conversion involves potentially mutagenic DNA modifications that need to be processed through DNA repair mechanisms (Teperek-Tkacz et al., 2011) . Our results show that an intact HR pathway is required for efficient reprogramming, even in the absence of viral integration or potential genome-modifying agents, such as the oncogene c-Myc. The complete loss of function of HR genes during reprogramming may lead to even more profound effects. HR genes may also have functions in addition to DNA repair during reprogramming. For example, Brca1 is implicated in basal transcriptional regulation (Mullan et al., 2006 ) and transcriptional (legend continued on next page) activation of several genes, including Sox2 (Kondo and Raff, 2004) . These additional roles may explain the stronger reprogramming phenotype observed in Brca1 mutant MEFs in comparison to Brca2 mutant cells. However, differences in genetic background and/or severity of the hypomorphic alleles used in this work may have also contributed to the phenotypic differences. Recent evidence that core components of the nucleotide excision repair pathway act as ESC-specific transcriptional coactivators regulating the expression of Nanog (Fong et al., 2011) raises the interesting possibility that additional DNA repair pathway components may also be co-opted in ESCs to maintain pluripotency. Finally, a better understanding of the role of DNA repair pathways during reprogramming will contribute to the identification of safer approaches for creating iPSCs. The generation of desired cell types for regenerative medicine can also be achieved with the use of more direct approaches, such as lineage reprogramming. When compared to pluripotency reprogramming, lineage reprogramming may involve less extensive epigenetic remodeling, and it does not typically rely on ectopic expression of classic oncogenes. For regenerative medicine, it will be crucial to determine whether lineage reprogramming induces levels of DNA damage similar to pluripotency reprogramming and to assess its mutagenic impact.
EXPERIMENTAL PROCEDURES

Mouse Strains
All animal experiments are approved by Institutional Animal Care and Use Committee (IACUC) of Memorial Sloan-Kettering Cancer Center.
Reprogramming and Generation of iPSC Lines
For reprogramming experiments, passage 2 MEFs were seeded at 2 3 10 5 cells per well of a 6-well dish. MEFs were infected twice on the next day with fresh viral supernatants. The day after infection, MEFs were replated at different specified densities on irradiated MEF feeder layers and cultured in mouse ESC media (knockout DMEM supplemented with 15% Hyclone FBS, L-glutamine, penicillin and streptomycin, nonessential amino acids, b-mercaptoethanol, and 1000 U/ml leukemia inhibitory factor). See Extended Experimental Procedures for a detailed description of the reprogramming experiments performed in this article.
Knockdown of Gene Expression with shRNAs
To knock down expression of Brca1, Brca2, and Rad51 genes, we obtained pLKO.1-puro lentiviral vectors expressing three different shRNAs per gene from Sigma-Aldrich (MISSION shRNA constructs). In all experiments, knockdown efficiency was assessed by qRT-PCR analyses 6 days after infection and compared to the expression of the corresponding gene in cells infected with an empty pLKO.1-puro control virus (Sigma-Aldrich, SHC001) ( Figures  S3D, S3E , S3G, S3H, and S4B). We used a well-characterized shRNA (MLSshp53) (Hemann et al., 2003) to knock down p53 expression and used the empty vector (MLS-empty) as a control ( Figure S4A ).
Alkaline Phosphatase and Immunofluorescence Staining
Alkaline phosphatase (AP) staining was performed with the use of a Vector Red Alkaline Phosphatase Substrate Kit according to the manufacturer's guidelines (Vector Laboratories, SK-5100). For nuclear immunostaining, cells were fixed with 4% paraformaldehyde in PBS for $10 min and stained by standard immunofluorescence staining procedures. The following primary antibodies were used: Nanog (Cosmo Bio, REC-RCAB0002P-F), Oct4 (Santa Cruz Biotechnology, sc-5279), Klf4 (Santa Cruz Biotechnology, sc-20691), and Sox2 (Santa Cruz Biotechnology, sc-17320). For SSEA1 surface marker expression analysis, live cells were directly stained for 30 min with an SSEA1 antibody conjugated with Alexa 488 (Santa Cruz Biotechnology, sc-21702 AF488) in PBS with 0.2% BSA. Figures S4C and S4D ).
Proliferation and Apoptosis Immunofluorescence Analysis
Flow Cytometric Analysis of gH2AX and SSEA1 Cells were first incubated with the SSEA1 antibody conjugated with Alexa 488 (described above) for 30 min. After the washing steps, cells were fixed in 70% ice cold ethanol and stored at À20 C for up to 2 weeks. Next, cells were incubated with a phospho-Histone H2A.X (Ser139) antibody (Millipore, followed by the Alexa 647 goat anti-mouse IgG1 secondary antibody (Life Technologies, A21240) for gH2AX detection. Finally, cells were stained with propidium iodide (PI) solution (PBS containing 5 mg/ml PI and 100 mg/ml RNase A) prior to flow cytometric analysis with a Becton Dickinson FACSCalibur.
Flow Cytometric Analysis of Annexin V and SSEA1
For apoptosis assays, flow cytometry was performed on cells stained with Annexin V-FITC (BD Pharmingen, 556547) and DAPI. In some experiments, cells were also stained with SSEA1-APC (R&D Systems, FAB2155A). In brief, cells were washed twice with PBS and stained with 0.5 ml of Annexin V-FITC (or with 0.5 ml of Annexin V-FITC and 4 ul SSEA1-APC) in 100 ml binding buffer (10 mM HEPES, [pH 7.4], 140 mM NaOH, 2.5 mM CaCl2) for 30 min at room temperature in the dark. Next, cells were washed twice with the binding buffer and then resuspended in a binding buffer containing 1 mg/ml DAPI. (I) Our results support a critical role of the HR pathway for efficient reprogramming. We propose a model in which reprogramming increases the level of DNA damage, which is responsible for the genetic aberrations observed in iPSC lines (indicated by a lightly shaded box). A defective HR pathway may lead to increased genetic aberration (indicated by dark shaded boxes) or the elimination of abnormal cells through p53-mediated cell-cycle arrest or apoptosis. See also Figure S4 .
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